| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |